TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review

The gut microbiota and its metabolites have become a hotspot of recent research. Trimethylamine N-oxide (TMAO) metabolized by the gut microbiota is closely related to many diseases such as cardiovascular disease, chronic kidney disease, type 2 diabetes, etc. Chronic kidney disease (CKD) is an import...

Descripción completa

Detalles Bibliográficos
Autores principales: Zixin, Ye, Lulu, Chen, Xiangchang, Zeng, Qing, Fang, Binjie, Zheng, Chunyang, Luo, Tai, Rao, Dongsheng, Ouyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411716/
https://www.ncbi.nlm.nih.gov/pubmed/36034781
http://dx.doi.org/10.3389/fphar.2022.929262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411716/
https://www.ncbi.nlm.nih.gov/pubmed/36034781
http://dx.doi.org/10.3389/fphar.2022.929262

Ejemplares similares